Showing results (81-90 of 93) with videos related to
Sort By:
Pageof 10
Journal of Nephrology|September 1, 2019
Pre-implantation kidney biopsy: value of the expertise in determining histological score and comparison with the whole organ on a series of discarded kidneysIlaria Girolami, Giovanni Gambaro, Claudio Ghimenton, et al.Journal of Clinical Apheresis|January 12, 2008
The role of immunomodulation in ABO-incompatible adult liver transplant recipientsLucio Urbani, Alessandro Mazzoni, Irene Bianco, et al.Pharmacogenomics|May 7, 2014
A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patientsMina Maftouh, Amir Avan, Niccola Funel, et al.Cancer Research|October 3, 2013
Crizotinib inhibits metabolic inactivation of gemcitabine in c-Met-driven pancreatic carcinomaAmir Avan, Viola Caretti, Niccola Funel, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 27, 2018
Pilot, Open, Randomized, Prospective Trial for Normothermic Machine Perfusion Evaluation in Liver Transplantation From Older DonorsDavide Ghinolfi, Erion Rreka, Vincenzo De Tata, et al.Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|June 24, 2024
Robotic Versus Open Pancreatoduodenectomy With Vein Resection and Reconstruction: A Propensity Score-Matched AnalysisNiccolò Napoli, Emanuele Federico Kauffmann, Michael Ginesini, et al.Plos One|November 17, 2012
High-throughput microRNA (miRNAs) arrays unravel the prognostic role of MiR-211 in pancreatic cancerElisa Giovannetti, Arjan van der Velde, Niccola Funel, et al.Cancers|July 7, 2019
Early Tumor Shrinkage and Depth of Response Evaluation in Metastatic Pancreatic Cancer Treated with First Line Chemotherapy: An Observational Retrospective Cohort StudyCaterina Vivaldi, Lorenzo Fornaro, Carla Cappelli, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2009
PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancerFotios Loupakis, Luca Pollina, Irene Stasi, et al.Oncology|September 12, 2023
Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with HistologyCaterina Vivaldi, Virginia Genovesi, Clara Ugolini, et al.Pageof 10